Clinical Trial: A Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatment With Botulinum Neurotoxin A

U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07374965) titled 'A Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatment With Botulinum Neurotoxin A' on Jan. 14.

Brief Summary: The goal of this observational study is to learn about the safety, tolerability, and effectiveness of Letibotulinumtoxin A for the holistic treatment of the upper face in adults under 75 years old with moderate to severe upper facial lines, including glabellar lines, forehead lines, and lateral canthal lines.

The main questions it aims to answer are:

* Does Letibotulinumtoxin A safely and effectively reduce the severity of glabellar lines, forehead lines, and later...